News

Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 16.4% in the morning session after the company reported strong fourth-quarter results that exceeded expectations, with same-store sales significantly surpassing analysts' forecasts and EPS outperforming Wall Street's estimates by a wide margin. Growth was powered by strong performance in the Pharmacy & Consumer Wellness segment​. On the other hand, its full-year EPS guidance missed. Despite this, we think this was a decent qua

Shares of scientific instruments company Waters Corporation (NYSE:WAT) fell 9% in the morning session after the company reported disappointing fourth quarter results: Its revenue and EPS guidance for next quarter fell short of Wall Street's estimates. whole, was underwhelming. The company highlighted headwinds related to foreign exchange, volume, and inflation. Also, the sales outlook suggests growth will trudge along in the mid-single digits, given foreign exchange pressures.

Shares of biopharmaceutical company Gilead Sciences (NASDAQ:GILD) jumped 8.6% in the morning session after the company reported impressive fourth-quarter results that exceeded analysts' revenue, EPS, and adjusted operating income estimates. Revenue grew 6%, driven by a 16% increase in HIV product sales and supported by strength in oncology and liver disease products. The momentum is expected to continue into the next year, as full-year EPS guidance surpassed Wall Street estimates, while sales gu

Surprisingly strong U.S. inflation in January stoked investor fears that a heating economy and looming tariffs could corner the Federal Reserve, undercutting interest rate-cut hopes and even raising the threat of a hike. U.S. consumer prices increased more than expected in January, reinforcing expectations the central bank will be in no rush to resume cutting interest rates, particularly as economic uncertainty is exacerbated by the expected inflationary impact of U.S. President Donald Trump's tariffs on key U.S. trade partners. Fed Chair Jerome Powell said in congressional testimony this week that the Fed was prepared to keep rates unchanged until inflation resumes its decline.

Tech stocks are off to a tough start this year. Well, except for Meta.

The investment bank isn't the only Wall Street titan gobbling up crypto.

Atlanta Federal Reserve President Raphael Bostic said on Wednesday it is not clear when the Fed can cut interest rates again given uncertainty around the path of inflation and the scope of possible changes to tariff and other policies coming from the Trump administration. "It's going to take a while to just figure out what is going on," Bostic said in a presentation to business executives in Atlanta as data showed inflation jumped in January and the administration was levying extensive new import taxes on basic metals and other goods.